Gut Microbiota for Health World Summit - Washington 2021

Program
2022 GMFH Summit

All times are in local time – Eastern Standard Time (EST), UTC -5


Friday, March 11

1 pm – Satellite symposium: Gut Health and the Microbiome – A Workshop for Registered Dietitians
By invitation only. This program is made possible by support from Danone North America.

3 pm – Registration (until 6 pm)


Saturday, March 12

7 am – Breakfast and Registration

8:30 am – Welcome
Gail A. Hecht, MD, MS, Loyola University Medical Center (U.S.) – virtual presentation

8:45 am – Keynote Lecture

The promise of the gut microbiome as part of individualized treatment strategies
Purna Kashyap, MBBS, Mayo Clinic (U.S.)

9:15 am – PLENARY SESSION 1: Impact of Diet on the Human Gut Microbiome
Moderator: Gary D. Wu, MD, University of Pennsylvania School of Medicine (U.S.)

  • Effect of immigration on the gut microbiome
    Dan Knights, PhD, University of Minnesota (U.S.) – virtual presentation
  • Effect of cooking on the microbiome
    Rachel Carmody, PhD, Harvard University (U.S.)
  • Metabolome patterns in response to diet – impact of microbiome
    Gary D. Wu, MD, University of Pennsylvania School of Medicine (U.S.)

10:45 am – Morning Break

11:15 am – PLENARY SESSION 2: Gut Microbiota in Precision Medicine
Moderator: Giovanni Barbara, MD, University of Bologna (Italy)

  • Precision nutrition and the human gut microbiome
    Nicola Segata, PhD, University of Trento (Italy) – virtual presentation
  • Brain-gut axis in functional gastrointestinal disorders
    Emeran Mayer, MD, UCLA (U.S.)– virtual presentation
  • Circadian rhythm and gut microbiome signatures in type 2 diabetes
    Dirk Haller, PhD, Technical University of Munich (Germany)

12:45 pm – Lunch

1:15 pm – Product Theater: The Power of the Microbiome – Can it be unlocked to break the cycle of recurrent Clostridioides difficile infection?
Paul Feuerstadt, MD, Yale-New Haven Hospital and PACT-Gastrocenter
Presented by Ferring Pharmaceuticals, Inc.

2 pm – Breakout Sessions (two concurrent sessions – in-person only)

  • Workshop 1: Defining a “healthy” microbiome
    Eugene B. Chang, MD, University of Chicago (U.S.)
    R. Balfour Sartor, MD, University of North Carolina-Chapel Hill (U.S.)
  • Workshop 2: Circadian control of microbiota functionality
    Dirk Haller, PhD, Technical University of Munich (Germany)
    Vanessa Leone, PhD, University of Wisconsin-Madison (U.S.)

3:15 pm – Afternoon Break

3:45 pm – Breakout Sessions (two concurrent sessions – in-person only)

  • Workshop 3: Designing microbiome trials – unique considerations
    Brendan J. Kelly, MD, University of Pennsylvania (U.S.)
    Geoffrey A. Preidis, MD, PhD, Baylor College of Medicine and Texas Children’s Hospital (U.S.)
  • Workshop 4: Modulating microbial pathways as a therapeutic strategy
    Gary D. Wu, MD, University of Pennsylvania (U.S.)
    Harry Sokol, MD, PhD, Sorbonne Université, APHP (France)– virtual presentation

5 pm – Networking Reception

7 pm – End of Day 1


Sunday, March 13

(Eastern Daylight Time starting 2 am on March 13)

7 am – Breakfast and Registration

8:30 am – PLENARY SESSION 3: Update on Microbiota-based Therapies
Moderator: Colleen R. Kelly, MD, Alpert Medical School of Brown University (U.S)

  • Status of commercial stool-based therapies
    Sahil Khanna, MD, Mayo Clinic (U.S.)
  • Mining the gut microbiota and identifying effector microbes to combat pathogen infection
    Kenya Honda, MD, PhD, Keio University School of Medicine (Japan) – virtual presentation
  • Microbiota as a modulator of cancer therapy
    Jennifer A. Wargo, MD, MMSc, MD Anderson Cancer Center (U.S.) – virtual presentation

10 am – Morning Break

10:30 am – PLENARY SESSION 4: Probiotics – Outlook for the Future
Moderator: Purna Kashyap, MBBS, Mayo Clinic (U.S.)

  • Rational selection of microbes as probiotics
    Eric Alm, PhD, MIT (U.S.)
  • Genetically engineered bacteria and synthetic bacteria as probiotics
    Philippe Langella, PhD, INRA (France)
  • Microbiota-derived small molecules as probiotics
    Sloan Devlin, PhD, Harvard Medical School (U.S.)

12 pm – Closing Lecture
COVID-19, the GI Tract, and the Microbiome: What Do We Know Today?
Siew C. Ng, MBBS, PhD, Chinese University of Hong Kong – virtual presentation.

12:30 pm – Closing Remarks
Harry Sokol, MD, PhD, Sorbonne Université, APHP (France) – virtual presentation

12:35 pm – End of Program


CME information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Gastroenterological Association (AGA) Institute and the European Society of Neurogastroenterology & Motility (ESNM).

The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians. The AGA Institute designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Gail A. Hecht, MD, MS (co-chair)

Harry Sokol, MD, PhD (co-chair)

Giovanni Barbara, MD

Joël Doré, PhD

Francisco Guarner, MD, PhD

Dirk Haller, PhD

Purna Kashyap, MBBS

Colleen R. Kelly, MD

Emeran A. Mayer, MD

D. Brent Polk, MD

R. Balfour Sartor, MD

Robert F. Schwabe, MD

Hania Szajewska, MD

Michael Trauner, MD

Gary D. Wu, MD